181 related articles for article (PubMed ID: 22203439)
1. Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months.
Zhang J; Pan JH; Dong BJ; Xue W; Liu DM; Huang YR
Fam Cancer; 2012 Jun; 11(2):209-14. PubMed ID: 22203439
[TBL] [Abstract][Full Text] [Related]
2. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study.
Kano H; Shuto T; Iwai Y; Sheehan J; Yamamoto M; McBride HL; Sato M; Serizawa T; Yomo S; Moriki A; Kohda Y; Young B; Suzuki S; Kenai H; Duma C; Kikuchi Y; Mathieu D; Akabane A; Nagano O; Kondziolka D; Lunsford LD
J Neurosurg; 2015 Jun; 122(6):1469-78. PubMed ID: 25816088
[TBL] [Abstract][Full Text] [Related]
5. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease.
Lonser RR; Butman JA; Huntoon K; Asthagiri AR; Wu T; Bakhtian KD; Chew EY; Zhuang Z; Linehan WM; Oldfield EH
J Neurosurg; 2014 May; 120(5):1055-62. PubMed ID: 24579662
[TBL] [Abstract][Full Text] [Related]
6. Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up.
Jilg CA; Neumann HP; Gläsker S; Schäfer O; Leiber C; Ardelt PU; Schwardt M; Schultze-Seemann W
Fam Cancer; 2012 Sep; 11(3):387-94. PubMed ID: 22426863
[TBL] [Abstract][Full Text] [Related]
7. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
[TBL] [Abstract][Full Text] [Related]
8. A 10-year retrospective study of hemangioblastomas of the central nervous system with reference to von Hippel-Lindau (VHL) disease.
Padhi S; Sarangi R; Challa S; Bussary P; Panigrahi MK; Purohit AK
J Clin Neurosci; 2011 Jul; 18(7):939-44. PubMed ID: 21570297
[TBL] [Abstract][Full Text] [Related]
9. Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease.
Ye DY; Bakhtian KD; Asthagiri AR; Lonser RR
J Neurosurg; 2012 Nov; 117(5):818-24. PubMed ID: 22937928
[TBL] [Abstract][Full Text] [Related]
10. Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease.
Mehta GU; Asthagiri AR; Bakhtian KD; Auh S; Oldfield EH; Lonser RR
J Neurosurg Spine; 2010 Mar; 12(3):233-42. PubMed ID: 20192620
[TBL] [Abstract][Full Text] [Related]
11. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease.
Asthagiri AR; Mehta GU; Zach L; Li X; Butman JA; Camphausen KA; Lonser RR
Neuro Oncol; 2010 Jan; 12(1):80-6. PubMed ID: 20150370
[TBL] [Abstract][Full Text] [Related]
13. Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
Capitanio U; Rosiello G; Erdem S; Rowe I; Kara O; Roussel E; Campi R; Klatte T; Kriegmair MC; Sibona M; Bertolo R; Ouzaid I; Mir MC; Marra G; Larcher A; Montorsi F; Salonia A;
World J Urol; 2021 Aug; 39(8):2969-2975. PubMed ID: 33416974
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease.
Niemelä M; Lemeta S; Summanen P; Böhling T; Sainio M; Kere J; Poussa K; Sankila R; Haapasalo H; Kääriäinen H; Pukkala E; Jääskeläinen J
Acta Neurochir (Wien); 1999; 141(11):1147-56. PubMed ID: 10592114
[TBL] [Abstract][Full Text] [Related]
15. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery.
Walther MM; Choyke PL; Glenn G; Lyne JC; Rayford W; Venzon D; Linehan WM
J Urol; 1999 May; 161(5):1475-9. PubMed ID: 10210376
[TBL] [Abstract][Full Text] [Related]
16. Long term outcomes for patients with von Hippel-Lindau and Pheochromocytoma: defining the role of active surveillance.
Sanford T; Gomella PT; Siddiqui R; Su D; An JY; Bratslavsky G; Ball MW; Linehan WM; Metwalli AR
Urol Oncol; 2021 Feb; 39(2):134.e1-134.e8. PubMed ID: 33303379
[TBL] [Abstract][Full Text] [Related]
17. Management of von Hippel-Lindau disease-associated CNS lesions.
Wind JJ; Lonser RR
Expert Rev Neurother; 2011 Oct; 11(10):1433-41. PubMed ID: 21955200
[TBL] [Abstract][Full Text] [Related]
18. The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience.
Zamarud A; Marianayagam NJ; Park DJ; Yener U; Yoo KH; Meola A; Chang SD
J Neurooncol; 2023 Nov; 165(2):373-379. PubMed ID: 37955759
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
20. Clinical and surgical features of lower brain stem hemangioblastomas in von Hippel-Lindau disease.
Pavesi G; Berlucchi S; Munari M; Manara R; Scienza R; Opocher G
Acta Neurochir (Wien); 2010 Feb; 152(2):287-92. PubMed ID: 19787293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
